Kura Oncology Inc (NAS:KURA)
$ 8.86 -0.08 (-0.89%) Market Cap: 688.99 Mil Enterprise Value: 250.32 Mil PE Ratio: 0 PB Ratio: 1.63 GF Score: 29/100

Kura Oncology Inc at JMP Securities Life Sciences Conference Transcript

May 16, 2023 / 03:00PM GMT
Release Date Price: $12.52 (-1.11%)
Unidentified Analyst

Excellent. So good morning, everyone, and welcome to the second day of the JMP Securities Life Science Conference. It's my pleasure to introduce Kura Oncology, a physician-based biopharmaceutical company presenting for the company's Troy Wilson, President and CEO. Welcome Troy.

Troy Wilson
Kura Oncology, Inc. - President & CEO

Thank you.

Unidentified Analyst

As I've said to many other companies who get on the stage with me here, I don't know who's in the audience and I don't know who's hitting the replay button, whether they know the Kura story or not. If you could, in three to five minutes, just give us an overview of Kura Oncology.

Troy Wilson
Kura Oncology, Inc. - President & CEO

Sure. Yeah. So thank you for the invitation to come to New York and to attend the conference and to give an overview and answer questions. So as the name would suggest, at Kura Oncology, we're focused on the development of targeted therapies for the treatment of cancer, both solid

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot